US FDA Requires Opioid Class Labeling Changes Despite Adcomm Advice

 
• By Kate Rawson
  
The FDA wants several changes to opioid labels. A few are captured here. (Screenshot of FDA Documents)

More from Post-Marketing Regulation & Studies

More from United States